SIBO Breath Test: At-Home and Finger-Prick Options, Normal Ranges, and What Results Mean

What Is the SIBO Breath Test and How Does It Work?

The SIBO breath test measures gases that gut bacteria produce when they ferment a sugar substrate you drink before the test. Bacteria in the small intestine produce hydrogen and methane as fermentation byproducts; those gases cross the intestinal wall, enter the bloodstream, and are exhaled through the lungs within minutes. A breath sample collected at timed intervals captures this gas curve and lets a clinician determine whether bacterial fermentation is occurring too early in the digestive tract. The North American Consensus on hydrogen and methane breath testing defines the procedural and interpretive standards that most labs follow today.

The Two Substrates: Lactulose vs. Glucose

Lactulose is a non-absorbable synthetic sugar. Because it travels the full length of the small intestine without being absorbed, it can detect SIBO anywhere along that segment, including the distal ileum. Its drawback is a higher false-positive rate caused by early arrival in the colon, which also ferments lactulose and can produce a rise that mimics SIBO. A 2020 systematic review in the American Journal of Gastroenterology reported lactulose sensitivity of roughly 52 to 68% and specificity of 83 to 86% across studies using a 20 ppm hydrogen cutoff.

Glucose is absorbed almost entirely in the proximal small intestine. Bacteria present in the jejunum or duodenum ferment glucose before absorption occurs, producing an early hydrogen peak. Because glucose never reaches the colon under normal conditions, a positive result carries fewer false positives. That same systematic review found glucose sensitivity of approximately 62 to 77% and specificity of 83 to 90% for proximal SIBO. The limitation is that glucose misses distal small-intestinal overgrowth entirely.

Hydrogen, Methane, and Hydrogen Sulfide

Most older breath-test devices measured only hydrogen. The 2017 North American Consensus published in the American Journal of Gastroenterology added methane as a required measurement because Methanobrevibacter smithii and related archaea produce CH4 rather than H2. Patients dominated by methane-producing organisms often present with constipation rather than diarrhea, a pattern now termed intestinal methanogen overgrowth (IMO). A third gas, hydrogen sulfide (H2S), may explain a subset of patients with negative hydrogen and methane results but ongoing symptoms; research published in Digestive Diseases and Sciences identified H2S as detectable in breath and associated with diarrhea-predominant presentations. The Trio-Smart device (Gemelli Biotech) is currently the only commercially available three-gas breath-test platform that measures all three simultaneously.

SIBO Breath Test Normal Range: What the Numbers Mean

Interpreting a breath test requires understanding baseline values, the shape of the gas curve, and the timing of any rise.

Hydrogen (H2) Cutoffs

A fasting baseline hydrogen reading below 10 ppm is considered normal. The diagnostic threshold for SIBO using hydrogen is a rise of more than 20 ppm above the fasting baseline within the first 90 minutes of the test. This cutoff comes from the 2017 North American Consensus and was reaffirmed in a 2022 review in Clinical and Translational Gastroenterology. A rise that occurs after 90 minutes more likely reflects colonic fermentation rather than small-intestinal overgrowth, though clinical context still matters.

Some practitioners apply a stricter threshold of a rise >12 ppm at 90 minutes to increase sensitivity. The tradeoff is lower specificity. Current guidelines do not endorse the 12 ppm cutoff as a primary standard.

Methane (CH4) Cutoffs

The 2017 North American Consensus defines a methane reading of 10 ppm or more at any single time point during the test as positive for IMO, regardless of whether there is also a hydrogen rise. Methane levels do not need to show a dynamic rise because methanogen populations tend to produce a relatively flat but elevated baseline throughout the test window. A study in Gut Microbes (2020) confirmed that the 10 ppm threshold had the best balance of sensitivity and specificity compared with lower or higher cutoffs.

What "Optimal" Looks Like on a Normal Test

A truly normal SIBO breath test shows:

• Fasting H2 below 10 ppm
• No H2 rise exceeding 20 ppm above baseline within 90 minutes
• CH4 below 10 ppm at every time point
• A single late rise in H2 (after 90 to 120 minutes) consistent with substrate reaching the colon

Patients who achieve all four of these criteria have, by current consensus definitions, no detectable SIBO or IMO. That does not exclude other causes of their symptoms, including dysbiosis, motility disorders, or food intolerance.

Elevated Baseline: A Separate Warning Sign

A fasting H2 above 20 ppm before the substrate is even consumed suggests recent high-fermentable-food intake, inadequate prep, or mouth bacteria contributing to readings. Most labs instruct patients to repeat the prep and retest rather than interpret a high-baseline result as positive for SIBO, per the North American Consensus protocol. The consensus document recommends patients follow a low-fermentation diet for at least 24 hours and fast for a minimum of 12 hours before testing.

At-Home SIBO Breath Test Options

At-home SIBO testing has expanded considerably since 2018. Mail-in breath-collection kits now match the analytical accuracy of in-office collections, provided patients follow the preparation and collection protocols precisely.

How At-Home Kits Work

At-home kits supply:

1. A substrate packet (lactulose or glucose powder mixed with water)
2. Timed breath-collection tubes or bags (typically 13 to 15 samples over 2 to 3 hours)
3. A prepaid return shipping label to a certified breath-test laboratory

The patient collects a fasting baseline breath sample, drinks the substrate solution, and then collects additional samples every 15 to 20 minutes. Tubes are sealed and mailed same-day or next-day for analysis. Results are typically returned within 3 to 7 business days via a secure patient portal.

Currently Available At-Home Platforms

Trio-Smart (Gemelli Biotech / Commonwealth Diagnostics International): The most clinically comprehensive at-home option. Measures hydrogen, methane, and hydrogen sulfide. Uses lactulose as substrate. Endorsed by several integrative gastroenterology practices and referenced in a 2021 paper in Nutrients evaluating three-gas breath testing in clinical practice.

Commonwealth Diagnostics International (CDI) Lactulose and Glucose Kits: Offer separate lactulose or glucose substrate options. Results include a gas curve graph and interpretation based on North American Consensus cutoffs. CDI holds CLIA certification for breath-test analysis.

QuinTron BreathTracker (clinic-based, also available for at-home collection): QuinTron devices are the reference standard for many academic GI programs. Some telehealth and functional-medicine providers ship QuinTron collection kits to patients and arrange courier pickup. QuinTron's analytical methodology has been validated against jejunal aspirate cultures in controlled studies.

Is There a Finger-Prick Option for SIBO?

No validated finger-prick or blood-based test exists for diagnosing active SIBO. Blood tests sometimes ordered alongside a SIBO workup include:

• Serum B12 and folate: Bacteria in the small intestine consume B12, so low serum B12 with elevated folate raises suspicion, though neither is diagnostic. A 2019 review in Nutrients noted that B12 deficiency is present in roughly 30 to 40% of patients with confirmed SIBO.
• Iodoacetate antibody panel (CytoScan / ibs-smart): This serum panel measures antibodies to anti-vinculin and anti-CdtB, proteins linked to post-infectious SIBO. A study in Digestive Diseases and Sciences (2015) found anti-CdtB elevated in 91% of patients with IBS-D linked to prior food poisoning. This panel identifies a likely cause rather than confirming active bacterial overgrowth.
• Organic acids urine test: Measures D-lactate and other bacterial metabolites; used in functional medicine as an indirect SIBO marker but lacks the sensitivity and specificity data of breath testing. No major gastroenterology society currently recommends it as a primary SIBO diagnostic tool.

The breath test remains the only non-invasive, guideline-supported method for diagnosing SIBO in outpatient practice. Jejunal aspirate culture (>10³ CFU/mL is the older gold standard; current consensus favors >10³ with symptoms) is more definitive but requires upper endoscopy and is rarely done outside research settings.

Preparing for Your SIBO Breath Test: Step-by-Step Protocol

Preparation errors are the single largest source of invalid results. The North American Consensus provides a detailed prep protocol that all patients and clinicians should follow.

The Low-Fermentation Diet (24 to 48 Hours Before)

For 24 to 48 hours before the test, patients should eat only foods that are fully absorbed before reaching the colon and leave minimal residue for fermentation. Permitted foods include:

• Baked or grilled chicken, fish, or turkey
• White rice
• Eggs
• Plain water, black coffee, or plain tea (no milk)

Foods to avoid include all vegetables, fruits, high-fiber grains, legumes, dairy, and any fermented foods. The ACG Clinical Guideline on small intestinal bacterial overgrowth (2020) specifies that dietary prep is mandatory for valid results.

The 12-Hour Fast

Nothing by mouth except plain water for at least 12 hours immediately before the test. Smoking, vigorous exercise, and sleep are also restricted on the morning of the test because they can alter breath gas concentrations.

Medications to Pause (With Physician Approval)

• Antibiotics: stop 4 weeks before testing
• Prokinetics (e.g., low-dose naltrexone, prucalopride): stop 1 week before
• Probiotics: stop 2 to 4 weeks before
• Laxatives or antidiarrheals: stop 1 week before

Stopping any prescription medication requires physician sign-off. Patients on rifaximin should not test until at least 4 weeks after their last dose, as residual antibiotic activity can suppress bacterial gas production and generate a false-negative result.

Interpreting Results and Next Steps

Positive Hydrogen SIBO

A hydrogen-positive result (H2 rise >20 ppm within 90 minutes) suggests hydrogen-producing bacterial overgrowth, most commonly gram-negative anaerobes such as Prevotella, Klebsiella, or Fusobacterium species. First-line treatment per the ACG 2020 guideline is rifaximin 550 mg three times daily for 14 days. The TARGET 3 trial demonstrated that rifaximin 550 mg three times daily for 14 days achieved symptom relief in 63.7% of IBS-D patients vs. 47.7% placebo (P<0.001), though that trial focused on IBS rather than culture-confirmed SIBO.

Positive Methane (IMO)

Methane positivity (≥10 ppm) requires different treatment. A 2021 study in the American Journal of Gastroenterology found that the combination of rifaximin 550 mg three times daily plus neomycin 500 mg twice daily for 14 days produced a 28% greater reduction in methane compared with rifaximin alone. Treating IMO with rifaximin alone is insufficient in most cases.

Negative Test With Ongoing Symptoms

A negative breath test does not rule out gut pathology. Possible explanations include:

• Distal SIBO missed by glucose substrate
• Hydrogen sulfide SIBO (requires Trio-Smart or similar three-gas device)
• Dysmotility, visceral hypersensitivity, or functional bowel disorder
• Incorrect prep leading to false-negative result

The ACG 2020 guideline recommends that clinicians with strong clinical suspicion and a negative breath test consider empiric antibiotic therapy or repeat testing with a different substrate before excluding SIBO as a diagnosis.

The HealthRX SIBO Test Selection Framework

Choosing the right at-home breath test depends on symptom pattern. The framework below maps presenting symptoms to substrate and device choice:

| Symptom Pattern | Preferred Substrate | Device Recommendation | |---|---|---| | Bloating, diarrhea, proximal symptoms | Glucose (75 g) | CDI Glucose Kit or QuinTron | | Bloating, constipation, fullness | Lactulose (8 g) | Trio-Smart (captures CH4) | | Mixed or unclear | Lactulose (8 g) | Trio-Smart (H2 + CH4 + H2S) | | Prior negative test, ongoing diarrhea | Lactulose (8 g) | Trio-Smart (rules out H2S) | | Post-antibiotic retest | Either | Same device as baseline for comparability |

Accuracy, Limitations, and When to Use Jejunal Aspirate

Sensitivity and Specificity of Breath Testing

Breath testing is not perfect. A 2023 meta-analysis in Alimentary Pharmacology and Therapeutics (N=2,877 patients across 21 studies) reported pooled sensitivity of 54% (95% CI 44 to 63%) and specificity of 83% (95% CI 76 to 88%) for lactulose breath testing using the 20 ppm cutoff. Glucose testing showed pooled sensitivity of 68% (95% CI 59 to 76%) and specificity of 85% (95% CI 78 to 90%). These numbers mean that a negative lactulose test does not exclude SIBO with high confidence.

When Jejunal Aspirate Culture Is Warranted

Jejunal aspirate culture is the reference-standard test, defined as growth of >10³ colony-forming units per mL of jejunal fluid. The ACG 2020 guideline notes that aspirate culture is appropriate when:

• Breath test results are equivocal and clinical suspicion is high
• Empiric antibiotic trials have failed
• The patient has anatomical risk factors (e.g., blind loop, stricture, or prior gastric bypass)

As the ACG guideline states directly: "Breath testing is appropriate for the initial evaluation of suspected SIBO given its non-invasive nature, but clinicians should recognize its diagnostic limitations and maintain clinical judgment." ACG Clinical Guideline, 2020

Orocecal Transit Time as a Confound

Orocecal transit time varies from approximately 70 to 120 minutes in healthy adults. A fast transiter may show a colonic hydrogen rise within 90 minutes even without SIBO, generating a false-positive. The North American Consensus recommends that the two-peak criterion (an early small-intestinal peak followed by a later colonic peak) be interpreted cautiously and that single early peaks not be over-interpreted without clinical context. Ghoshal et al. (2017) specifically addressed this confound in the consensus document.

Who Should Get a SIBO Breath Test?

Clinical Indications

The ACG 2020 Clinical Guideline on SIBO lists the following as appropriate indications for breath testing:

• Unexplained bloating, flatulence, or abdominal distension
• Chronic diarrhea without identified etiology
• Malabsorption or unexplained weight loss
• IBS-D or IBS-M that has not responded to first-line dietary modification
• Conditions associated with motility impairment (diabetes, scleroderma, hypothyroidism)
• History of abdominal surgery creating blind loops or adhesions
• Proton pump inhibitor use exceeding 6 months with GI symptoms

Who Should Not Test Without Medical Supervision

Patients on active antibiotic therapy, those who have completed antibiotics within 4 weeks, and patients with known inflammatory bowel disease flare should not undergo breath testing until those conditions are addressed. Breath testing in active Crohn's disease or ulcerative colitis flare may produce misleading results due to altered gut transit and increased mucosal gas production. A 2019 review in the World Journal of Gastroenterology highlighted this limitation in IBD populations.

Cost, Access, and Insurance Coverage

At-home SIBO breath test kits range from approximately $189 to $369 depending on the platform and number of gases measured. The Trio-Smart three-gas kit lists at $329 as of early 2025. Insurance coverage is inconsistent. Some PPO plans cover SIBO breath testing under CPT code 91065 (hydrogen breath test) when ordered by a physician with a documented clinical indication. Medicare does not consistently reimburse at-home collection kits.

Patients using HSA or FSA accounts can generally apply those funds to breath-test kits when ordered by a licensed provider, as SIBO breath testing qualifies as a diagnostic test for a specific medical condition under IRS Publication 502.